Natsar Pharmaceuticals, Inc.
Pharmaceuticals · ELLICOTT CITY, MD
PharmaceuticalsSEC Form D
Natsar Pharmaceuticals, Inc. filed a Form D with the U.S. Securities and Exchange Commission on May 8, 2026 for a private securities offering.
Incorporated in Delaware and based in ELLICOTT CITY, MD, it operates in the Pharmaceuticals sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Natsar Pharmaceuticals, Inc. has raised capital from private investors.
Browse more recently funded companies in Pharmaceuticals.
Executives & Directors
- Venu RamanExecutive Officer · Director
Recently funded in Pharmaceuticals
Other companies that recently filed a Form D
$3.0MRaised
FibroBiologics, Inc.
$200.0KRaised
Balsam Pharmaceuticals Co
$750.0KRaised
Eos SENOLYTIX, Inc.
$1.9MRaised
Liminatus Pharma, Inc.
$384.8KRaised